Cigna Ventures

Cigna Ventures, now operating as The Cigna Group Ventures, is the strategic corporate venture capital fund of The Cigna Group (NYSE: CI), one of the world's largest health service companies with over 190 million customer relationships across 30-plus countries. Founded in 2018 and based in Bloomfield, Connecticut, the firm received an initial $250 million capital commitment that enabled 19 direct investments, followed by an additional $450 million investment announced to drive healthcare transformation. With 44 investments made to date, the portfolio is organized around three pillars: insights and analytics, digital health and experience, and care delivery and enablement. Cigna Ventures deploys checks of $3 million to $30 million at the Series A through growth stages. Notable portfolio companies include Arcadia in population health management, AristaMD in eConsult platforms, Babyscripts in virtual maternity care, Buoy Health in AI health navigation, Cleerly in cardiac AI, Datavant in health data connectivity, Ginger in behavioral health, Omada in chronic condition management, and Prognos Health in clinical analytics. Managing Director Jasmi Shah leads the firm's ambition to be the strategic venture capital partner of choice for healthcare startups making care more affordable, simple, and predictable. The Cigna Group's massive customer base and integrated healthcare infrastructure give portfolio companies commercial pathways and validation that few other corporate venture investors in healthcare can match — making Cigna Ventures a strategically valuable partner for companies seeking both capital and accelerated market access.